A Pilot Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)
The purpose of this research is to evaluate and determine the rate of successful administration of Percussive ventilation breathhold (PVB) to allow for more accurate radiotherapy for lung tumors.
• Arm 1: Healthy volunteers age 18 or older
• Arm 1: Ability to understand and the willingness to sign (personally or by a legal authorized representative) the written IRB approved informed consent document.
• Arm 2: Patients with a diagnosis of primary lung cancer or lung metastases of any primary tumor origin
• Arm 2: Patients deemed clinically eligible to be treated with standard of care lung SABR for patient arm
• Arm 2: Patients of any gender age 18 or older
• Arm 2: Patients with ECOG Performance Status 0-2 and select patients with Performance Status 3 deemed to be suitable candidates based on common sense clinical judgment on the risks versus benefits of SABR
• Arm 2: Ability to understand and the willingness to sign (personally or by a legal authorized representative) the written IRB approved informed consent document.